Model
Edge
Alnylam Pharmaceuticals, Inc.
0001829252
Filing Type
144
Filing Date
3/20/2025
Updated
3/21/25, 2:03 PM
Filing
144
Earnings Release
Exhibits
144
Notice of Proposed Sale of Securities